S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ECARX Holdings Inc. stock logo
ECX
ECARX
$1.68
+1.8%
$2.27
$1.65
$9.34
$557.62M0.1384,821 shs16,978 shs
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
$36.76
-2.4%
$36.80
$31.25
$39.31
N/AN/A13,658 shs23,373 shs
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
C$0.18
+2.9%
C$0.18
C$0.15
C$0.44
C$68.09MN/A169,986 shs73,804 shs
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
$0.00
$0.16
$0.62
N/AN/A1,714 shs51,582 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ECARX Holdings Inc. stock logo
ECX
ECARX
+1.82%-12.50%-15.15%-26.96%-68.60%
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
-2.39%-5.91%-1.34%+5.54%+7.08%
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
0.00%0.00%0.00%0.00%0.00%
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ECARX Holdings Inc. stock logo
ECX
ECARX
1.3281 of 5 stars
3.52.00.00.02.70.80.0
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/AN/AN/AN/AN/AN/AN/AN/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/AN/AN/AN/AN/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ECARX Holdings Inc. stock logo
ECX
ECARX
3.00
Buy$10.00495.24% Upside
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/AN/AN/AN/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ECARX Holdings Inc. stock logo
ECX
ECARX
$657.10M0.86N/AN/A($0.35) per share-4.80
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
$9.46MN/AN/AN/AN/AN/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/AN/AN/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ECARX Holdings Inc. stock logo
ECX
ECARX
-$132.42M-$0.38N/AN/A-20.03%N/A-23.13%6/10/2024 (Estimated)
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/A-$0.03N/AN/AN/AN/AN/AN/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/AN/A0.00N/AN/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest VP, NTG, ECX, REDD, and SGF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/28/2024Q4 2023
ECARX Holdings Inc. stock logo
ECX
ECARX
N/A-$0.12-$0.12-$0.12N/A$263.10 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ECARX Holdings Inc. stock logo
ECX
ECARX
N/AN/AN/AN/AN/A
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
$3.088.38%+1.22%N/A N/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
C$0.28155.56%N/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/A

Latest VP, NTG, ECX, REDD, and SGF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/7/2024
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
quarterly$0.779%2/21/20242/22/20242/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ECARX Holdings Inc. stock logo
ECX
ECARX
N/A
0.78
0.74
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/AN/AN/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ECARX Holdings Inc. stock logo
ECX
ECARX
N/A
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
ECARX Holdings Inc. stock logo
ECX
ECARX
20.00%
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/A
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
N/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ECARX Holdings Inc. stock logo
ECX
ECARX
2,020337.95 million270.36 millionNot Optionable
Tortoise Midstream Energy Fund, Inc. stock logo
NTG
Tortoise Midstream Energy Fund
N/AN/AN/ANot Optionable
812575 (SGF.TO) stock logo
SGF
812575 (SGF.TO)
147,000378.28 millionN/ANot Optionable
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/ANot Optionable

VP, NTG, ECX, REDD, and SGF Headlines

SourceHeadline
COVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™COVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™
tmcnet.com - March 27 at 1:27 PM
States drug pricing boards off to a slow startStates' drug pricing boards off to a slow start
msn.com - March 22 at 8:16 AM
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
mmm-online.com - March 20 at 6:45 PM
Verrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference CallVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Call
msn.com - February 25 at 2:28 PM
Abivax appoints Ana Sharma as Vice President, Global Head of QualityAbivax appoints Ana Sharma as Vice President, Global Head of Quality
markets.businessinsider.com - February 7 at 8:56 AM
Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s HealthMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health
markets.businessinsider.com - January 24 at 1:10 PM
Senior Vice PresidentSenior Vice President
govtech.com - December 20 at 9:06 AM
Dr Reddys becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023Dr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023
msn.com - December 14 at 3:30 PM
Biden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patents
msn.com - December 7 at 3:45 PM
The White House is threatening the patents of high-priced drugs developed with taxpayer dollarsThe White House is threatening the patents of high-priced drugs developed with taxpayer dollars
abcnews.go.com - December 7 at 9:38 AM
Amneal Pharma in pact with Strides to launch generic VascepaAmneal Pharma in pact with Strides to launch generic Vascepa
msn.com - December 1 at 3:25 PM
Anavex Life Sciences Appoints Senior VP of Regulatory AffairsAnavex Life Sciences Appoints Senior VP of Regulatory Affairs
markets.businessinsider.com - November 6 at 8:21 AM
Xpengs vice president suspended amid corruption investigation in supply chain managementXpeng's vice president suspended amid corruption investigation in supply chain management
foxnews.com - October 14 at 11:38 PM
Lexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart DrugLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drug
marketwatch.com - October 9 at 6:33 PM
Strengthening of vertical integration: Exyte completes acquisition of pure media specialist IntegaStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Intega
markets.businessinsider.com - October 4 at 6:44 AM
Vice PresidentVice President
newsweek.com - September 19 at 1:02 PM
Republican voters want Donald Trump. And his vice president? How about more Trump?Republican voters want Donald Trump. And his vice president? How about more Trump?
usatoday.com - August 28 at 4:23 AM
Teva Pharmaceuticals to pay $225M fine to settle price-fixing chargesTeva Pharmaceuticals to pay $225M fine to settle price-fixing charges
news.yahoo.com - August 22 at 4:12 AM
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call TranscriptVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
msn.com - August 1 at 10:03 PM
See which pharma brands are the strongest and fastest-growing in 2023See which pharma brands are the strongest and fastest-growing in 2023
mmm-online.com - July 12 at 1:54 PM
Senior Vice President, Corporate Development and Global StrategySenior Vice President, Corporate Development and Global Strategy
webmd.com - June 9 at 11:51 PM
What has Kamala Harris done as vice president?What has Kamala Harris done as vice president?
news.yahoo.com - May 29 at 8:36 AM
AHIP Marketing Campaign Targets Pharma’s Prescription Drug PricingAHIP Marketing Campaign Targets Pharma’s Prescription Drug Pricing
healthpayerintelligence.com - April 24 at 7:41 PM
Meet our President and Vice ChancellorMeet our President and Vice Chancellor
lse.ac.uk - April 9 at 10:43 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ECARX logo

ECARX

NASDAQ:ECX
ECARX Holdings Inc. develops a full stack automotive computing platform to shape the interaction between people and cars by rapidly advancing the technology by smart mobility worldwide. It offers system on chips, central computing platforms, operating systems, and software. Its core products include infotainment head units, digital cockpits, vehicle chip-set solutions, core operating system, and integrated software stack. The company has entered into a strategic partnership agreement with Black Sesame Technologies. The company is based in Shanghai, the People's Republic of China.
Tortoise Midstream Energy Fund logo

Tortoise Midstream Energy Fund

NYSE:NTG
Tortoise MLP Fund, Inc. is a close ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. It invests in public equity markets. The fund primarily invests in equity securities of MLPs and their affiliates, with an emphasis on natural gas infrastructure Master Limited Partnerships. It employs a fundamental analysis with a bottom up stock picking approach with focus on factors like quantitative, qualitative, and relative value factors to create its portfolio. Tortoise MLP Fund, Inc. was formed on July 27, 2010 is domiciled in United States.
812575 (SGF.TO) logo

812575 (SGF.TO)

TSE:SGF
Shore Gold Inc. is a Canada-based company, which is engaged in the exploration, development and production of diamonds. The Company's mineral property holdings include the Star Kimberlite Property (Project), which is located in the central part of Saskatchewan, Canada; the Fort a la Corne Joint Venture (FALC-JV) Property, which is located in central Saskatchewan, Canada, and Buffalo Hills Joint Venture, which is located in central Alberta, Canada. The Company's Star-Orion South Diamond Project includes the Star Diamond Project, as well as Star West and the Orion South Kimberlite. The Company acts as an operator of the FALC-JV. The Company's subsidiaries include Shore Mining & Development Corp. and Kensington Resources Ltd.
Vodis Pharmaceuticals logo

Vodis Pharmaceuticals

CNSX:VP
Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.